Y-Intercept (HK)
IMCR icon

Y-Intercept (HK)’s Immunocore IMCR Stock Holding History

Y-Intercept (HK)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.95M Sell
97,515
-29,137
-23% -$991K 0.07% 436
2026
Q2 		$4.02M Buy
126,652
+91,725
+263% +$2.71M 0.08% 356
2026
Q1 		$1.05M Sell
34,927
-13,260
-28% -$429K 0.02% 1012
2025
Q4 		$1.67M Buy
48,187
+2,856
+6% +$101K 0.04% 706
2025
Q3 		$1.65M Sell
45,331
-6,332
-12% -$215K 0.04% 721
2025
Q2 		$1.62M Buy
+51,663
New +$1.6M 0.04% 696
2024
Q3 		– Sell
-31,265
Closed -$1.06M – 1537
2024
Q2 		$1.06M Buy
+31,265
New +$1.59M 0.06% 465

Other funds holding IMCR

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Y-Intercept (HK)'s IMCR Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Immunocore (IMCR) stake by 23% in Q3 2026, selling an estimated $991K and leaving 97,515 shares worth $2.95M. The position accounts for 0.07% of the portfolio, ranked #436.

Y-Intercept (HK) first reported a position in IMCR in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.02M in Q2 2026. 12 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Y-Intercept (HK) held 97,515 shares of Immunocore worth $2.95M as of Q3 2026.
  • Y-Intercept (HK) sold 29,137 Immunocore shares in Q3 2026, an estimated $991K.
  • Immunocore made up 0.07% of Y-Intercept (HK)'s portfolio in Q3 2026, its #436 holding.
  • Y-Intercept (HK) first reported a position in Immunocore in Q2 2024 and has held it in 7 quarters since.
  • Y-Intercept (HK)'s Immunocore position peaked at $4.02M in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.